GeekWire Awards: Billion-dollar deals, rare IPO, pharma pact, and mega-round vie for Deal of the Year

GeekWire Awards: Billion-dollar deals, rare IPO, pharma pact, and mega-round vie for Deal of the Year

The 2026 GeekWire Awards: Deal of the Year Finalists Showcase Billion-Dollar Tech Exits and Rare IPO

The 2026 GeekWire Awards’ Deal of the Year category has unveiled an extraordinary lineup of transactions that collectively represent billions of dollars in value and signal the continued dynamism of Seattle’s tech ecosystem. Presented by Wilson Sonsini, this prestigious award recognizes the most impactful transactions in technology and innovation across Seattle and the broader Pacific Northwest region.

A Historic Year for Tech Transactions

This year’s finalists—Kestra Medical Technologies, Omeros, Protect AI, Statsig, and Temporal—represent a diverse cross-section of the tech landscape, from AI infrastructure to cybersecurity, medical devices, and pharmaceutical licensing deals. Together, these transactions have reshaped the competitive landscape and demonstrated the region’s continued ability to produce companies that attract major strategic interest.

The GeekWire Awards, now in their 18th year, have become the premier celebration of Pacific Northwest tech leadership, innovation, and entrepreneurial achievement. The awards ceremony will take place May 7 at Seattle’s Showbox SoDo, bringing together hundreds of industry leaders to celebrate the region’s technological achievements.

Statsig: The $1.1 Billion OpenAI Acquisition

In what industry observers called one of the most surprising exits of the year, Bellevue-based Statsig was acquired by OpenAI in September for $1.1 billion in an all-stock transaction. The deal not only represented a significant exit for the product experimentation platform but also brought Statsig CEO Vijaye Raji into a newly created role as OpenAI’s CTO of Applications.

Founded in 2021, Statsig had quickly established itself as a leader in A/B testing, feature flagging, and real-time decisioning for major enterprises. The company had raised over $153 million, including a $100 million Series C round at a $1.1 billion valuation just months before the acquisition, with backing from top-tier investors Sequoia and Madrona.

The acquisition represents more than just a financial transaction—it positions Statsig as the nucleus of OpenAI’s new Bellevue engineering office, creating a significant engineering hub in the Seattle area and demonstrating the region’s continued importance in the AI revolution.

Kestra Medical Technologies: Breaking the IPO Drought

Kestra Medical Technologies’ $202 million initial public offering in March 2025 marked a watershed moment for Seattle-area tech companies. The Kirkland-based maker of wearable cardiac devices priced its shares above the expected range, with shares beginning trading on the Nasdaq at more than 30% above the IPO price.

The offering ended a long drought for traditional IPOs among Seattle-area tech companies, with no such offerings since 2021. Founded in 2014, Kestra develops devices that detect and respond to sudden cardiac arrest, addressing a critical need in medical technology. The successful IPO demonstrates renewed investor appetite for health tech companies with strong fundamentals and clear paths to profitability.

Omeros Corporation: The $2.1 Billion Pharmaceutical Deal

Seattle-based biopharmaceutical company Omeros Corporation struck a landmark deal with pharmaceutical giant Novo Nordisk worth up to $2.1 billion for zaltenibart, its clinical-stage drug candidate in development for rare blood and kidney disorders. Announced in October, the agreement gives Novo Nordisk exclusive global rights to develop and commercialize the drug.

Founded in 1994 by orthopedic surgeon Gregory A. Demopulos, who continues to serve as CEO, Omeros went public in 2009 and has maintained its independence while building a robust pipeline of drug candidates. The company recently received FDA approval for its lead drug Yartemlea, the first therapy for a rare post-transplant complication, demonstrating its ability to bring innovative treatments to market.

Protect AI: Cybersecurity’s AI-Powered Future

Protect AI, a Seattle startup that helps companies secure machine learning systems, agreed to be acquired by cybersecurity giant Palo Alto Networks in April. While terms were not disclosed, sources familiar with the deal said it was valued north of $500 million.

Founded in 2022 by former engineering leaders at Amazon and Oracle, Protect AI serves Fortune 500 companies across finance, healthcare, and government. The acquisition reflects the growing importance of AI security as organizations increasingly deploy machine learning systems across their operations. Palo Alto Networks stated that the deal will bolster its ability to secure the new attack surfaces created by AI, positioning the combined entity at the forefront of next-generation cybersecurity.

Temporal: Riding the AI Wave to $5 Billion Valuation

Temporal raised $300 million in a Series D round at a $5 billion valuation in February, doubling its valuation from just months earlier. The Bellevue-based company builds open-source software and a cloud service that helps companies run complex workflows reliably—what it calls “durable execution.”

The rise of AI agents has amplified demand for Temporal’s platform, with customers including OpenAI, ADP, and Block. Founded in 2019 by co-founders Samar Abbas and Maxim Fateev, who previously built an internal orchestration engine at Uber, Temporal has raised $650 million to date, with backing from Andreeseen Horowitz, Sequoia, and Madrona.

The Broader Impact on Pacific Northwest Tech

These transactions collectively demonstrate the maturation of Seattle’s tech ecosystem and its ability to produce companies that attract major strategic interest across multiple sectors. From AI infrastructure to medical devices and pharmaceuticals, the diversity of the finalists showcases the region’s technological breadth and depth.

The success of these companies also highlights the importance of patient capital and strategic vision in building enduring technology companies. Several of the finalists, including Omeros and Kestra, took the public market route, while others found strategic acquirers that could provide the resources and scale to accelerate their missions.

Looking Ahead

As voting for the Deal of the Year award continues through April 10, the tech community is weighing not just the financial magnitude of these transactions but their strategic importance and potential to reshape their respective industries. The winner will be announced at the May 7 awards ceremony, where the broader impact of these deals on Seattle’s tech ecosystem will be celebrated.

The 2026 GeekWire Awards, presented by Astound Business Solutions with gold sponsors including Amazon Sustainability, Baird, BECU, JLL, First Tech, and Wilson Sonsini, represents more than just an awards ceremony—it’s a testament to the innovation, resilience, and entrepreneurial spirit that continues to define the Pacific Northwest’s technology sector.

AI acquisitions, billion-dollar exits, IPO drought broken, Seattle tech ecosystem, Pacific Northwest innovation, medical device IPO, pharmaceutical licensing, cybersecurity AI, durable execution, workflow orchestration, venture capital, strategic acquisitions, tech M&A, startup exits, engineering talent, AI infrastructure, health tech, biotech deals, public market returns, enterprise software, open-source companies, venture funding, unicorn startups, technology transactions, innovation awards, GeekWire Awards, Wilson Sonsini, Seattle startups, Bellevue tech hub, Kirkland companies, venture capital returns, strategic acquirers, patient capital, tech diversity, industry reshaping, entrepreneurial spirit, technological breadth, patient capital, strategic vision, enduring companies, public market route, strategic acquirers, financial magnitude, strategic importance, industry reshaping, innovation celebration, resilience, entrepreneurial spirit, Pacific Northwest technology

This year’s Deal of the Year finalists represent the pinnacle of Pacific Northwest tech achievement, showcasing how the region continues to produce world-class companies that attract global attention and investment. Whether through IPOs, strategic acquisitions, or landmark licensing deals, these transactions demonstrate that Seattle’s tech ecosystem remains vibrant, innovative, and capable of producing returns that rival any tech hub in the world.

The diversity of the finalists—spanning AI infrastructure, cybersecurity, medical devices, and pharmaceuticals—also points to the maturation of the local ecosystem beyond its traditional strengths in software and e-commerce. As these companies continue to grow and evolve, they’re creating new opportunities for talent, investment, and innovation throughout the region.

What makes this year’s finalists particularly compelling is not just their financial scale but their strategic importance. Each transaction represents a bet on the future of technology—whether that’s the continued integration of AI into enterprise workflows, the critical importance of securing AI systems, the potential of medical devices to transform healthcare, or the ongoing promise of biotechnology to address unmet medical needs.

As the tech community gathers to celebrate these achievements in May, the Deal of the Year award will recognize not just financial success but the vision, execution, and impact that these companies have demonstrated. In doing so, it will highlight once again why the Pacific Northwest remains one of the most dynamic and innovative tech ecosystems in the world.

,

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply

Your email address will not be published. Required fields are marked *